Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Circulation Research|December 5, 2009
Phospholamban ablation rescues sarcoplasmic reticulum Ca(2+) handling but exacerbates cardiac dysfunction in CaMKIIdelta(C) transgenic miceTong Zhang, Tao Guo, Shikha Mishra, et al.
The Journal of Physiology|February 25, 2009
Muscle-specific VEGF deficiency greatly reduces exercise endurance in miceI Mark Olfert, Richard A Howlett, Kechun Tang, et al.
Circulation|April 10, 2002
Rebuilding a damaged heart: long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac functionJochen Müller-Ehmsen, Kirk L Peterson, Larry Kedes, et al.
Circulation|December 17, 2021
PRDM16 Is a Compact Myocardium-Enriched Transcription Factor Required to Maintain Compact Myocardial Cardiomyocyte Identity in Left VentricleTongbin Wu, Zhengyu Liang, Zengming Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2002
Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularizationTracy L Bale, Frank J Giordano, Reed P Hickey, et al.
Cardiovascular Research|June 2, 2005
Gene transfer of a phospholamban-targeted antibody improves calcium handling and cardiac function in heart failureThomas Dieterle, Markus Meyer, Yusu Gu, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 5, 2014
Discoidin domain receptor 2 germline gene deletion leads to altered heart structure and function in the mouseRandy T Cowling, Seon Ju Yeo, In Jai Kim, et al.
Circulation Research|December 14, 2011
Thymosin beta 4 is dispensable for murine cardiac development and functionIndroneal Banerjee, Jianlin Zhang, Thomas Moore-Morris, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|March 2, 2013
Impaired exercise capacity and skeletal muscle function in a mouse model of pulmonary inflammationKechun Tang, George Murano, Harrieth Wagner, et al.
Hypertension (Dallas, Tex. : 1979)|February 11, 2009
Immediate and sustained blood pressure lowering by urocortin 2: a novel approach to antihypertensive therapy?Thomas Dieterle, Silvia Meili-Butz, Katrin Bühler, et al.
Pageof 8